60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.390
+0.140 (11.20%)
At close: Oct 2, 2026, 4:00 PM EDT
1.408
+0.018 (1.32%)
After-hours: Oct 2, 2026, 7:52 PM EDT
60 Degrees Pharmaceuticals Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$404,977
Profits / Employee
-$2,874,812
Market Cap
4.89M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| AIM ImmunoTech | 21 |
| Processa Pharmaceuticals | 12 |
| Dermata Therapeutics | 9 |
| Lexaria Bioscience | 7 |
| Ernexa Therapeutics | 7 |
| Can-Fite BioPharma | 5 |
| GRI Bio | 4 |
SXTP News
- 1 day ago - 60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar - GlobeNewsWire
- 21 days ago - 60 Degrees Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - 60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 7 weeks ago - 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results - GlobeNewsWire
- 7 weeks ago - 60 Degrees Pharmaceuticals Registration statement: Registration filing - Filings
- 7 weeks ago - 60 Degrees Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 7 weeks ago - 60 Degrees Pharmaceuticals Earnings release: Q2 2026 - Filings
- 2 months ago - 60 Degrees Pharmaceuticals to sell shares and warrants in private placement - TheFly